Table 2 Hazard ratio and 95% confidence interval for risk estimates of patient, renal allograft and hepatic outcomes in both groups before/after propensity scoring matching.
Before PSM | After PSM | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
HCV | Non-HCV | HCV | Non-HCV | |||||||
Number | Events | Number | Events | Hazard Ratio (95% CI) | Number | Events | Number | Events | Hazard Ratio (95% CI) | |
Death | 6,000 | 1,367 | 170,861 | 27,204 | 1.43(1.354, 1.509)*** | 5,986 | 1,367 | 6,084 | 1,050 | 1.19(1.098, 1.290)*** |
Graft failure | 2,859 | 317 | 97,288 | 14,325 | 0.697(0.623, 0.779)*** | 2,853 | 316 | 2,469 | 338 | 0.696(0.597, 0.812)*** |
Rejection | 5,337 | 315 | 149,778 | 14,407 | 0.561(0.502, 0.628)*** | 5,326 | 315 | 5,147 | 373 | 0.694(0.598, 0.807)*** |
Hepatoma | 5,061 | 126 | 177,598 | 356 | 12.12(9.891, 14.852)*** | 5,054 | 126 | 6,319 | 16 | 8.957(5.324, 15.069)*** |
Cirrhosis | 2,794 | 327 | 171,165 | 2,795 | 7.418(6.615, 8.319)*** | 2,790 | 326 | 5,736 | 120 | 5.378(4.363, 6.631)*** |
Hepatic failure | 4,147 | 211 | 172,363 | 2,003 | 4.261(3.697, 4.910)*** | 4,142 | 211 | 5,830 | 83 | 3.258(2.527, 4.200)*** |
Overall hepatic disease | 2,539 | 329 | 168,654 | 4,158 | 5.425(4.849, 6.070)*** | 2,536 | 329 | 5,585 | 168 | 4.128(3.428, 4.971)*** |